Список литературы

Поставить закладку

Адамян Л. В. Состояние репродуктивной системы у больных доброкачественными опухолями внутренних гениталий и принципы восстановительного лечения: Дис.… д-ра мед. наук //Москва. – 1985. Москва.
El-Balat A. et al. Modern Myoma Treatment in the Last 20 Years: A Review of the Literature //BioMed research international. – 2018. – Т. 2018. .
Pérez-López F. R. et al. EMAS position statement: management of uterine fibroids //Maturitas. – 2014. – Т. 79. – №. 1. – С. 106-116. .
Kubik-Huch R. A. et al. European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas //European radiology. – 2018. – Т. 28. – №. 8. – С. 3125-3137. .
Grings A. O. et al. Protein expression of estrogen receptors α and β and aromatase in myometrium and uterine leiomyoma //Gynecologic and obstetric investigation. – 2012. – Т. 73. – №. 2. – С. 113-117. .
He C, Nelson W et al. Frequency of MED12 Mutation in Relation to Tumor and Patient’s Clinical Characteristics: a Meta-analysis. Reprod Sci. 2022 Feb;29(2):357-365. .
Markowski D. N. et al. HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications //Anticancer research. – 2011. – Т. 31. – №. 3. – С. 753-761.
Ciavattini A. et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction //Obstetrics and gynecology international. – 2013. – Т. 2013. .
Mittal P. et al. Med12 gain-of-function mutation causes leiomyomas and genomic instability //The Journal of clinical investigation. – 2015. – Т. 125. – №. 8. – С. 3280-3284. .
Osinovskaya N. S. et al. Frequency and spectrum of MED12 exon 2 mutations in multiple versus solitary uterine leiomyomas from Russian patients //International journal of gynecological pathology. – 2016. – Т. 35. – №. 6. – С. 509-515. .
Tal R., Segars J. H. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy //Human reproduction update. – 2013. – Т. 20. – №. 2. – С. 194-216. .
Сидорова И. С. и др. Современное состояние вопроса о патогенезе, клинике, диагностике и лечении миомы матки у женщин репродуктивного возраста //Акушерство, гинекология и репродукция. – 2012. – Т. 6. – №. 4. .
Ren Y. et al. Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma //Fertility and sterility. – 2011. – Т. 96. – №. 4. – С. 1015-1020. e1. .
Plewka D. et al. Expression of VEGF isoforms and their receptors in uterine myomas //Ginekologia polska. – 2016. – Т. 87. – №. 3. – С. 166-177. .
Q Yang et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment// Endocr Rev, 2022 Jul 13;43(4):678-719. .
C Millien et al. Assessing burden, risk factors, and perceived impact of uterine fibroids on women’s lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study// Int J Equity Health 2021. .
Pavone D. et al. Epidemiology and risk factors of uterine fibroids //Best Practice & Research Clinical Obstetrics & Gynaecology. – 2018. – Т. 46. – С. 3-11. .
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet Gynecol. 2021 Jun 1;137(6):e100-e115. doi: 10.1097/AOG.0000000000004401. .
Серов В. Н., Сухих Г. Т. Клинические рекомендации. Акушерство и гинекология //М: ГЭОТАР-Медиа.-4-е изд.-2017. Москва: Проблемы репродукции.
Donnez J., Donnez O., Dolmans M. M. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? //Fertility and Sterility. – 2014. – Т. 102. – №. 3. – С. 640-648. .
Worldwide A. A. M. I. G. AAGL practice report: practice guidelines for the management of hysteroscopic distending media:(replaces hysteroscopic fluid monitoring guidelines. J Am Assoc Gynecol Laparosc. 2000; 7: 167–168.) //Journal of minimally invasive gy. .
SOGC clinical practice guideline, The Management of Uterine Leiomyomas, No. 318. .
Stewart E. A. et al. Epidemiology of uterine fibroids: a systematic review //BJOG: An International Journal of Obstetrics & Gynaecology. – 2017. – Т. 124. – №. 10. – С. 1501-1512. .
Zepiridis L. I., Grimbizis G. F., Tarlatzis B. C. Infertility and uterine fibroids //Best Practice & Research Clinical Obstetrics & Gynaecology. – 2016. – Т. 34. – С. 66-73. .
Parazzini F., Tozzi L., Bianchi S. Pregnancy outcome and uterine fibroids //Best practice & research Clinical obstetrics & gynaecology. – 2016. – Т. 34. – С. 74-84. .
Munro M. G. et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age //International Journal of Gynecology & Obstetrics. – 2011. – Т. 113. – №. 1. – С. 3-13. .
Munro M. G. et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions //International Journal of Gynecology & Obstetrics. – 2018. – Т. . .
Suzuki A. et al. Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma Using Magnetic Resonance Images: A Literature Review //Healthcare. – Multidisciplinary Digital Publishing Institute, 2019. – Т. 7. – №. 4. – С. 158. .
Савельева Г. М. и др. Национальное руководство //Акушерство–М.: Гэотар-Медиа. – 2015. .
Marret H. et al. Therapeutic management of uterine fibroid tumors: updated French guidelines //European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2012. – Т. 165. – №. 2. – С. 156-164. .
Fascilla F. D. et al. Ultrasound diagnosis of uterine myomas //Minerva ginecologica. – 2016. – Т. 68. – №. 3. – С. 297-312. .
Minsart A. F. et al. Does three‐dimensional power Doppler ultrasound predict histopathological findings of uterine fibroids? A preliminary study //Ultrasound in obstetrics & gynecology. – 2012. – Т. 40. – №. 6. – С. 714-720. .
Levine D. J. et al. Sensitivity of myoma imaging using laparoscopic ultrasound compared with magnetic resonance imaging and transvaginal ultrasound //Journal of minimally invasive gynecology. – 2013. – Т. 20. – №. 6. – С. 770-774. .
Yang T. et al. Sonohysterography: Principles, technique and role in diagnosis of endometrial pathology //World journal of radiology. – 2013. – Т. 5. – №. 3. – С. 81. .
Woźniak A., Woźniak S. Ultrasonography of uterine leiomyomas //Przeglad menopauzalny= Menopause review. – 2017. – Т. 16. – №. 4. – С. 113. .
Dueholm M. et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas //American journal of obstetrics and gynecology. – 2002. – Т. 186. – №. 3. – С. 409-415. .
Martucci C et al. Uterine leiomyoma in pediatric population: A case report and review of the literature. Front Pediatr. 2022. .
Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020. .
David DA, Rodrigues ÂR, Amaral J, Geraldes F. Submucous leiomyoma: an uncommon cause of heavy menstrual bleeding in early adolescence. BMJ Case Rep. 2024. .
De La Cruz M. S., Buchanan E. M. Uterine fibroids: diagnosis and treatment //Am Fam Physician. – 2017. – Т. 95. – №. 2. – С. 100-107. .
Donnez J., Dolmans M. M. Uterine fibroid management: from the present to the future //Human Reproduction Update. – 2016. – Т. 22. – №. 6. – С. 665-686. .
Barcelos N. B. et al. Clinicopathological study of cystic and atypical uterine leiomyoma: a rare entity //Jornal Brasileiro de Patologia e Medicina Laboratorial. – 2021. .
Ciccarone F. et al. Diagnosis of uterine leiomyosarcoma 5 years after magnetic‐resonance‐guided high‐intensity focused ultrasound treatment of fibroid //Ultrasound in Obstetrics & Gynecology. – 2022. .
Takeda A., Koike W., Watanabe K. Multimodal imaging for diagnosis and management of parasitic peritoneal myoma with myxoid degeneration after laparoscopic‐assisted myomectomy with electric power morcellation //Journal of Obstetrics and Gynaecology Researc. .
Roberts M. E., Aynardi J. T., Chu C. S. Uterine leiomyosarcoma: A review of the literature and update on management options //Gynecologic oncology. – 2018. .
Eder S. et al. Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids //Women’s health. – 2013. – Т. 9. – №. 4. – С. 397-403. .
Bitzer J. et al. Medical management of heavy menstrual bleeding: a comprehensive review of the literature //Obstetrical & gynecological survey. – 2015. – Т. 70. – №. 2. – С. 115-130. .
Lukes A. S. et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial //Obstetrics & Gynecology. – 2010. – Т. 116. – №. 4. – С. 865-875. .
Bryant-Smith, A.C. Antifibrinolytics for heavy menstrual bleeding / A.C. Bryant-Smith, A. Lethaby, C. Farquhar, M. Hickey // Cochrane Database Syst Rev. – 2018. – Issue 4. .
The Royal Children’s Hospital, Melbourne, Australia, Clinical Practice Guideline on Adolescent gynaecology - Heavy menstrual bleeding [Internet, last updated August 2020. .
Naoulou, B. Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review // B. Naoulou, M.C. Tsai // Acta Obstet Gynecol Scand. – 2012. – vol.91. – N 5. – P. 529-537. .
Синчихин С. П. и др. Дисменорея-современный взгляд на этиологию, патогенез, диагностику, клинику и лечение (обзор литературы) //Астраханский медицинский журнал. – 2010. .
Lethaby A., Duckitt K., Farquhar C. Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding //Cochrane database of systematic reviews. – 2013. – №. 1. .
Ichigo S. et al. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist //Archives of gynecology and obstetrics. – 2011. – Т. 284. – №. 3. – С. 667-670. .
Bofill Rodriguez M, Lethaby A, Jordan V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2020. .
Heavy menstrual bleeding: assessment and management NICE guideline [NG88] Published date: 14 March 2018 Last updated: 31 March 2020. .
De Silva N 2019, Abnormal uterine bleeding in adolescents: Management [Internet]. UpToDate. Available from: https://www.uptodate.com/contents/abnormal-uterine-bleeding-in-adolescents-management. .
Bofill M. R. et al. Cyclical progestogens for heavy menstrual bleeding //The Cochrane database of systematic reviews. – 2019. – Т. 8. – С. CD001016-CD001016. .
Lethaby A., Puscasiu L., Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids //Cochrane Database of Systematic Reviews. – 2017. – №. 11. .
Qin J. et al. Oral contraceptive use and uterine leiomyoma risk: a meta-analysis based on cohort and case–control studies //Archives of gynecology and obstetrics. – 2013. – Т. 288. – №. 1. – С. 139-148. .
Mas A. et al. Updated approaches for management of uterine fibroids //International journal of women’s health. – 2017. – Т. 9. – С. 607. .
Zhang Y. et al. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis //Obstetrical & gynecological survey. – 2014. – Т. 69. – №. 2. – С. 100-108. .
P Laberge, A Murji, G A. Vilos, C Allaire, N Leyland, S Singh Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas//Journal of Obstetrics and Gynaecology Canada V 41, I 10, 2019. .
Tristan M. et al. Mifepristone for uterine fibroids //Cochrane Database of Systematic Reviews. – 2012. – №. 8. .
Тихомиров А.Л., Деды Т.В. и др. Актуальная стратегия ведения пациенток с миомой матки в амбулаторных условиях // Трудный пациент. 2021. №4. .
M Engman , S Granberg, A R W Williams, C X Meng, P G L Lalitkumar, K Gemzell-Danielsson Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial// Hum Reprod, 2009. .
J Steinauer, E A Pritts, R Jackson, A F Jacoby Systematic review of mifepristone for the treatment of uterine leiomyomata// Obstet Gynecol, 2004. .
A Murji , L Whitaker , T L Chow , M L Sobel Selective progesterone receptor modulators (SPRMs) for uterine fibroids// Cochrane Database Syst Rev, 2017. .
Gupta M. et al. A prospective interventional study to evaluate the effects of medical therapy (Mifepristone 25 mg) on the management of uterine fibroids //Journal of Family Medicine and Primary Care. – 2020. .
Chittawar P. B. et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids //Cochrane Database of Systematic Reviews. – 2014. – №. 10. .
Sandberg E. M. et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis //Fertility and sterility. – 2018. – Т. 109. – №. 4. – С. 698-707. e1. .
Kongnyuy E. J., Wiysonge C. S. Interventions to reduce haemorrhage during myomectomy for fibroids //Cochrane Database of Systematic Reviews. – 2014. – №. 8. John Wiley & Sons, Ltd.
ACOG. Leiomyomas P. Uterine Morcellation for Presumed Leiomyomas. – 2019. .
Gkrozou F. et al. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies //Archives of gynecology and obstetrics. – 2015. – Т. 291. – №. 6. – С. 1347-1354. .
Yin X. et al. Hysteroscopic tissue removal systems for the treatment of intrauterine pathology: a systematic review and meta-analysis //Facts, views & vision in ObGyn. – 2018. – Т. 10. – №. 4. – С. 207. .
Sesti F. et al. Randomized comparison of total laparoscopic, laparoscopically assisted vaginal and vaginal hysterectomies for myomatous uteri //Archives of gynecology and obstetrics. – 2014. – Т. 290. – №. 3. – С. 485-491. .
“Fonseca M. C. M. et al. Uterine artery embolization and surgical methods for the treatment of symptomatic uterine leiomyomas: a systemic review and meta-analysis followed by indirect treatment comparison //Clinical therapeutics. – 2017. – Т. 39. – №. 7. –,” doi: 10.1016/j.clinthera.2017.05.346.
Gupta J. K. et al. Uterine artery embolization for symptomatic uterine fibroids //Cochrane Database of Systematic Reviews. – 2014. – №. 12. John Wiley & Sons, Ltd.
Czuczwar P. et al. Comparison of the influence of three fibroid treatment options: Supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve–an observational study //Journal of ovarian research. – 2018. – Т. 11. – №. .
Quinn S. D. et al. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids //European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2014. – Т. 182. – С. 247-251., vol. 182. .
Rabinovici J. et al. Pregnancy outcome after magnetic resonance–guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids //Fertility and sterility. – 2010. – Т. 93. – №. 1. – С. 199-209. .
Кравченко Е. Н. и др. Реабилитация после гинекологических операций в репродуктивном возрасте //Мать и дитя в Кузбассе. – 2019. .
Дугиева М. З. Оптимизация физиотерапевтических технологий в ранней реабилитации больных после операций по поводу миомы матки. автореферат диссер. док. мед. наук //Москва. – 2015. .
Favilli A. et al. Impact of FIGO type 3 uterine fibroids on in vitro fertilization outcomes: a systematic review and meta‐analysis //International Journal of Gynecology & Obstetrics. – 2023. .
Pritts E. A. Fibroids and infertility: a systematic review of the evidence //Obstetrical & gynecological survey. – 2001. – Т. 56. – №. 8. .
Carranza-Mamane B. et al. The management of uterine fibroids in women with otherwise unexplained infertility //Journal of Obstetrics and Gynaecology Canada. – 2015. – Т. 37. – №. 3. – С. 277-285. .
Milazzo G. N. et al. Myoma and myomectomy: Poor evidence concern in pregnancy //Journal of Obstetrics and Gynaecology Research. – 2017. .
Radosa M. P. et al. Laparoscopic myomectomy in peri-and post-menopausal women is safe, efficacious and associated with long-term patient satisfaction //European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2012. – Т. 162. – №. 2. – С. 19. .
Ulin M. et al. Uterine fibroids in menopause and perimenopause //Menopause. – 2019. .
Lethaby A. E., Vollenhoven B. J. An evidence-based approach to hormonal therapies for premenopausal women with fibroids //Best Practice & Research Clinical Obstetrics & Gynaecology. – 2008. – Т. 22. – №. 2. – С. 307-331. .
Kaganov H., Ades A., Fraser D. S. Preoperative magnetic resonance imaging diagnostic features of uterine leiomyosarcomas: a systematic review //International journal of technology assessment in health care. – 2018. – Т. 34. – №. 2. – С. 172-179. .
Ludovisi M. et al. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma //Ultrasound in Obstetrics & Gynecology. – 2019. – Т. 54. – №. 5. – С. 676-687. .